Vise Technologies Inc. Purchases New Shares in Encompass Health Corporation $EHC

Vise Technologies Inc. purchased a new position in shares of Encompass Health Corporation (NYSE:EHC) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 6,585 shares of the company’s stock, valued at approximately $808,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. WPG Advisers LLC purchased a new position in shares of Encompass Health in the 1st quarter worth approximately $27,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Encompass Health by 749.0% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 416 shares of the company’s stock worth $42,000 after acquiring an additional 367 shares during the period. Parkside Financial Bank & Trust boosted its position in Encompass Health by 179.5% in the second quarter. Parkside Financial Bank & Trust now owns 478 shares of the company’s stock worth $59,000 after purchasing an additional 307 shares during the last quarter. Park Place Capital Corp bought a new position in Encompass Health in the 2nd quarter valued at $72,000. Finally, Caitong International Asset Management Co. Ltd increased its position in shares of Encompass Health by 19.0% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock valued at $73,000 after purchasing an additional 115 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Stock Performance

NYSE:EHC opened at $114.32 on Friday. The business’s fifty day moving average is $122.88 and its 200 day moving average is $119.68. The firm has a market cap of $11.50 billion, a price-to-earnings ratio of 21.61, a PEG ratio of 2.20 and a beta of 0.91. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06. Encompass Health Corporation has a 52-week low of $87.85 and a 52-week high of $127.99.

Encompass Health (NYSE:EHC) last posted its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. Encompass Health had a return on equity of 18.19% and a net margin of 9.33%.The business had revenue of $136.30 million during the quarter. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Research analysts predict that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a $0.19 dividend. The ex-dividend date is Friday, January 2nd. This represents a $0.76 annualized dividend and a yield of 0.7%. Encompass Health’s dividend payout ratio is currently 14.37%.

Insider Buying and Selling

In other news, EVP Patrick William Tuer sold 1,020 shares of the business’s stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the completion of the transaction, the executive vice president directly owned 18,846 shares in the company, valued at $2,329,177.14. The trade was a 5.13% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.00% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on EHC. Raymond James Financial raised shares of Encompass Health to a “strong-buy” rating in a report on Friday, October 31st. KeyCorp boosted their target price on shares of Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research note on Tuesday, September 16th. UBS Group raised their price target on shares of Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a research note on Thursday, October 2nd. Truist Financial upped their price objective on Encompass Health from $135.00 to $140.00 and gave the company a “buy” rating in a research note on Thursday, August 14th. Finally, Bank of America increased their price objective on Encompass Health from $145.00 to $160.00 and gave the company a “buy” rating in a report on Wednesday, September 10th. Three research analysts have rated the stock with a Strong Buy rating and eight have issued a Buy rating to the company. According to MarketBeat, Encompass Health presently has an average rating of “Buy” and an average price target of $142.86.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.